Key Factors to Consider Before Investing in BBWI

Shares of Bath & Body Works have moved 2.2% today, and are now trading at a price of $37.26. In contrast, the S&P 500 index saw a -1.0% change. Today's trading volume is 2,591,441 compared to the stock's average volume of 3,855,140.

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. Based in Columbus, United States the company has 8,800 full time employees and a market cap of $8,471,078,912. Bath & Body Works currently offers its equity investors a dividend that yields 2.2% per year.

The company is now trading -22.03% away from its average analyst target price of $47.78 per share. The 18 analysts following the stock have set target prices ranging from $37.0 to $68.0, and on average give Bath & Body Works a rating of buy.

Over the last 12 months BBWI shares have declined by -0.0%, which represents a difference of -15.0% when compared to the S&P 500. The stock's 52 week high is $49.55 per share and its 52 week low is $30.52. Based on Bath & Body Works's average net margin growth of 4.8% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023-03-17 7,560,000 800,000 11 -35.29
2022-03-18 7,882,000 1,333,000 17 30.77
2021-03-19 6,434,000 844,000 13 285.71
2020-03-30 5,405,000 -366,000 -7 -240.0
2019-03-22 13,237,000 644,000 5 -37.5
2018-03-23 12,632,000 983,000 8
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.